🇰🇷 Ids-Ne-007 in South Korea

Ids-Ne-007 (ETORPHINE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Ids-Ne-007 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in South Korea

Frequently asked questions

Is Ids-Ne-007 approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Ids-Ne-007 in South Korea?

Marketing authorisation holder not available in our data.